phase ii study of all-oral aaa regimen for patients with newly diagnosed apl
Published 1 year ago • 129 plays • Length 3:10Download video MP4
Download video MP3
Similar videos
-
2:07
phase i/ii study of edit-301, a novel gene-edited autologous hsc medicine, in patients with scd
-
1:02
a phase ii single-arm study of obinutuzumab plus ibrutinib as frontline treatment for fl and mzl
-
2:03
preliminary results of a phase ii study of fedratinib in patients with mds/mpn and cnl
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
2:48
second acl revision vs. nonsurgical management
-
1:31
pembrolizumab plus avd in chl: long-term follow-up of a phase ii study
-
1:49
treating cll in the r/r setting: switching drug classes and investigational therapies
-
3:52
a phase ii study evaluating the safety and efficacy of olutasidenib in patients with r/r midh1 aml
-
1:44
insights into the phase ii tidal study
-
2:43
insights into phase i/ii study assessing fixed-duration glofitamab treatment for r/r lbcl
-
1:45
a phase ii study of elritercept for lower-risk mds
-
3:56
results of the phase ii titan study of caplacizumab in patients with attp
-
1:48
a phase ii study of daratumumab and pomalidomide in previously treated patients with al amyloidosis
-
5:00
long-term results of the phase ii revive study evaluating rusfertide in patients with pv
-
2:41
a phase i/ii study of afm13 in combination with cord blood-derived nk cells in patients with r/r hl
-
3:18
a phase i study of jbh492, an anti-ccr7 antibody-drug conjugate, in lymphoid malignancies
-
1:19
insights into a phase i/ia study of venetoclax, ixazomib and dexamethasone for r/r al amyloidosis
-
8:40
lenalidomide, mutations & mds outcomes